Skip to main content

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Publication ,  Journal Article
Piccini, JP; Jones, WS
Published in: N Engl J Med
February 1, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

February 1, 2018

Volume

378

Issue

5

Start / End Page

486

Location

United States

Related Subject Headings

  • Warfarin
  • Stroke
  • Percutaneous Coronary Intervention
  • Humans
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Dabigatran
  • Atrial Fibrillation
  • Anticoagulants
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., & Jones, W. S. (2018). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med, 378(5), 486. https://doi.org/10.1056/NEJMc1715183
Piccini, Jonathan P., and W Schuyler Jones. “Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.N Engl J Med 378, no. 5 (February 1, 2018): 486. https://doi.org/10.1056/NEJMc1715183.
Piccini JP, Jones WS. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2018 Feb 1;378(5):486.
Piccini, Jonathan P., and W. Schuyler Jones. “Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.N Engl J Med, vol. 378, no. 5, Feb. 2018, p. 486. Pubmed, doi:10.1056/NEJMc1715183.
Piccini JP, Jones WS. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2018 Feb 1;378(5):486.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

February 1, 2018

Volume

378

Issue

5

Start / End Page

486

Location

United States

Related Subject Headings

  • Warfarin
  • Stroke
  • Percutaneous Coronary Intervention
  • Humans
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Dabigatran
  • Atrial Fibrillation
  • Anticoagulants
  • 42 Health sciences